A carregar...
Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature
BACKGROUND: Medicinal products that have been developed and approved for one disease may be the object of additional clinical development in other disease areas or of additional pharmaceutical development for new and different formulations. The newly developed products can be named as repositioned o...
Na minha lista:
| Publicado no: | J Mark Access Health Policy |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Co-Action Publishing
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4865745/ https://ncbi.nlm.nih.gov/pubmed/27226826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/jmahp.v1i0.21131 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|